Event-Driven Stocks

Pfenex Inc.

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

Signs5 good3 warningdetails ↓

Financials

SEC XBRL · annual
 FY19FY18FY17FY16FY15FY14
Revenue$7.9M$3.7M$2.8M$60.2M$9.6M$10.6M
Operating income$824,000−$39.9M−$26.0M$5.1M−$27.8M−$9.7M
Net income−$6.1M−$11.0M−$10.0M$5.5M−$28.2M−$9.8M
Total assets$84.9M$81.3M$79.4M$103.1M$131.7M$71.0M
Total liabilities$12.6M$20.1M$21.6M$23.0M$60.5M$11.1M
Equity$72.3M$61.1M$57.8M$80.1M$71.2M$59.9M
EPS (diluted)$-0.19$-0.35$-1.26$-1.04
Shares out.31.5M23.6M23.4M23.4M20.5M20.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2019
Operating margin
10.5%
Net margin
−77.1%
Return on equity
−8.4%
Return on assets
−7.1%
Return on capital (ROCE)
1.1%
Liabilities / assets
14.8%
Debt / equity
0.17×
Book value / share
$2.30
Revenue growth (YoY)
109.9%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2019
Altman Z″ (distress)
2.68safe
Accruals / assets
2.3%clean
Beneish M-Score
-0.89elevated
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
68
/ 100
Profitability 40Growth 100Catalyst 33Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 warning5 good
  • Reported a net loss
  • Negative operating cash flow
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Insider transactions

SEC Form 4 · most recent
0 acquisitions7 disposalsnet 4.8M shares · last 7
InsiderDateTypeSharesPrice
Schneider Phillip MDirectorOct 1, 2020U11,000
Lucy Patrick K.Officer — Chief Business OfficerOct 1, 2020U90,246
Campbell RobinDirectorOct 1, 2020U5,000
Grenfell-Gardner JasonDirectorOct 1, 2020U10,000
Schimmelpennink Evert B.Officer — See RemarksOct 1, 2020U16,658
Weiss Asset Management Lp10% ownerSep 30, 2020U801,424$12.00
Newtyn Management, Llc10% ownerSep 30, 2020U3.9M

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.